Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Petrie

Showing results (381-390 of 557) with videos related to

Pageof 56
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|December 3, 2014
Implication of right ventricular dysfunction on long-term outcome in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting with or without surgical ventricular reconstructionTomasz Kukulski, Lilin She, Normand Racine, et al.
The Lancet. Diabetes & Endocrinology|January 23, 2025
Semaglutide in obesity-related heart failure with preserved ejection fraction and type 2 diabetes across baseline HbA<sub>1c</sub> levels (STEP-HFpEF DM): a prespecified analysis of heart failure and metabolic outcomes from a randomised, placebo-controlled trialMelanie J Davies, Peter van der Meer, Subodh Verma, et al.
Journal of the American Heart Association|March 12, 2024
Temporal Trends in the Initiation of Dialysis Among Patients With Heart Failure With or Without Diabetes: A Nationwide Study From 2002 to 2016Pauline Knigge, Sørine Lundberg, Jarl E Strange, et al.
European Heart Journal|November 8, 2024
Centrally adjudicated vs. investigator-reported outcomes in randomized heart failure trialsSimon Wandel, Akshay S Desai, Chien-Wei Chen, et al.
JACC. Heart Failure|June 13, 2021
Heart Failure Hospitalization in Adults Receiving Hemodialysis and the Effect of Intravenous Iron TherapyPardeep S Jhund, Mark C Petrie, Michele Robertson, et al.
JAMA Cardiology|October 3, 2022
Effect of Dapagliflozin on Cause-Specific Mortality in Patients With Heart Failure Across the Spectrum of Ejection Fraction: A Participant-Level Pooled Analysis of DAPA-HF and DELIVERAkshay S Desai, Pardeep S Jhund, Brian L Claggett, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 7, 2023
A novel, small-volume subcutaneous furosemide formulation delivered by an abdominal patch infusor device in patients with heart failure: results of two phase I studiesJoanna Osmanska, Katriona Brooksbank, Kieran F Docherty, et al.
Journal of the American Heart Association|February 25, 2016
Temporal Evolution of Myocardial Hemorrhage and Edema in Patients After Acute ST-Segment Elevation Myocardial Infarction: Pathophysiological Insights and Clinical ImplicationsDavid Carrick, Caroline Haig, Nadeem Ahmed, et al.
Journal of Cardiac Failure|November 5, 2023
The Impact of Ferric Derisomaltose on Cardiovascular and Noncardiovascular Events in Patients With Anemia, Iron Deficiency, and Heart Failure With Reduced Ejection FractionRobin Ray, Ian Ford, John G F Cleland, et al.
Cardiovascular Research|December 7, 2021
High-dose intravenous iron reduces myocardial infarction in patients on haemodialysisMark C Petrie, Pardeep S Jhund, Eugene Connolly, et al.
Pageof 56

Showing results (381-390 of 557) with videos related to

Sort By:
Pageof 56
The Journal of Thoracic and Cardiovascular Surgery|December 3, 2014
Implication of right ventricular dysfunction on long-term outcome in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting with or without surgical ventricular reconstructionTomasz Kukulski, Lilin She, Normand Racine, et al.
The Lancet. Diabetes & Endocrinology|January 23, 2025
Semaglutide in obesity-related heart failure with preserved ejection fraction and type 2 diabetes across baseline HbA<sub>1c</sub> levels (STEP-HFpEF DM): a prespecified analysis of heart failure and metabolic outcomes from a randomised, placebo-controlled trialMelanie J Davies, Peter van der Meer, Subodh Verma, et al.
Journal of the American Heart Association|March 12, 2024
Temporal Trends in the Initiation of Dialysis Among Patients With Heart Failure With or Without Diabetes: A Nationwide Study From 2002 to 2016Pauline Knigge, Sørine Lundberg, Jarl E Strange, et al.
European Heart Journal|November 8, 2024
Centrally adjudicated vs. investigator-reported outcomes in randomized heart failure trialsSimon Wandel, Akshay S Desai, Chien-Wei Chen, et al.
JACC. Heart Failure|June 13, 2021
Heart Failure Hospitalization in Adults Receiving Hemodialysis and the Effect of Intravenous Iron TherapyPardeep S Jhund, Mark C Petrie, Michele Robertson, et al.
JAMA Cardiology|October 3, 2022
Effect of Dapagliflozin on Cause-Specific Mortality in Patients With Heart Failure Across the Spectrum of Ejection Fraction: A Participant-Level Pooled Analysis of DAPA-HF and DELIVERAkshay S Desai, Pardeep S Jhund, Brian L Claggett, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 7, 2023
A novel, small-volume subcutaneous furosemide formulation delivered by an abdominal patch infusor device in patients with heart failure: results of two phase I studiesJoanna Osmanska, Katriona Brooksbank, Kieran F Docherty, et al.
Journal of the American Heart Association|February 25, 2016
Temporal Evolution of Myocardial Hemorrhage and Edema in Patients After Acute ST-Segment Elevation Myocardial Infarction: Pathophysiological Insights and Clinical ImplicationsDavid Carrick, Caroline Haig, Nadeem Ahmed, et al.
Journal of Cardiac Failure|November 5, 2023
The Impact of Ferric Derisomaltose on Cardiovascular and Noncardiovascular Events in Patients With Anemia, Iron Deficiency, and Heart Failure With Reduced Ejection FractionRobin Ray, Ian Ford, John G F Cleland, et al.
Cardiovascular Research|December 7, 2021
High-dose intravenous iron reduces myocardial infarction in patients on haemodialysisMark C Petrie, Pardeep S Jhund, Eugene Connolly, et al.
Pageof 56